All Stories

  1. Distinct microbiome composition and metabolome exists across subgroups of elite Irish athletes
  2. Metabolic phenotyping of the human microbiome
  3. Production of multiple bacteriocins, including the novel bacteriocin gassericin M, by Lactobacillus gasseri LM19, a strain isolated from human milk
  4. First evidence of production of the lantibiotic nisin P
  5. Identification and characterisation of capidermicin, a novel bacteriocin produced by Staphylococcus capitis
  6. Caprine milk fermentation enhances the antithrombotic properties of cheese polar lipids
  7. The Potential Impact of Probiotics on the Gut Microbiome of Athletes
  8. Improvement of Feed Efficiency in Pigs through Microbial Modulation via Fecal Microbiota Transplantation in Sows and Dietary Supplementation of Inulin in Offspring
  9. Four men in a boat: Ultra-endurance exercise alters the gut microbiome
  10. Cholestasis induced by bile duct ligation promotes changes in the intestinal microbiome in mice
  11. Diversity and composition of the gut microbiota of Atlantic salmon ( Salmo salar ) farmed in Irish waters
  12. Porcine Feed Efficiency-Associated Intestinal Microbiota and Physiological Traits: Finding Consistent Cross-Locational Biomarkers for Residual Feed Intake
  13. Analysis of Health Benefits Conferred by Lactobacillus Species from Kefir
  14. Potential for enriching next-generation health-promoting gut bacteria through prebiotics and other dietary components
  15. Brevibacillus laterosporus strains BGSP7, BGSP9 and BGSP11 isolated from silage produce broad spectrum multi-antimicrobials
  16. Influence of the Intestinal Microbiota on Colonization Resistance to Salmonella and the Shedding Pattern of Naturally Exposed Pigs
  17. Biofilms in Food Processing Environments: Challenges and Opportunities
  18. The dynamics of the antibiotic resistome in the feces of freshly weaned pigs following therapeutic administration of oxytetracycline
  19. Multiparametric liquid biopsy analysis in metastatic prostate cancer
  20. Dietary α-lactalbumin alters energy balance, gut microbiota composition and intestinal nutrient transporter expression in high-fat diet-fed mice
  21. The effect of ovine milk fermentation on the antithrombotic properties of polar lipids
  22. Lactobacillus gasseri APC 678 Reduces Shedding of the Pathogen Clostridium difficile in a Murine Model
  23. Moderate-intensity aerobic and resistance exercise is safe and favorably influences body composition in patients with quiescent Inflammatory Bowel Disease: a randomized controlled cross-over trial
  24. Short-term consumption of a high-fat diet increases host susceptibility to Listeria monocytogenes infection
  25. Bioengineering Nisin to overcome the Nisin Resistance Protein
  26. In silico Prediction and Exploration of Potential Bacteriocin Gene Clusters Within the Bacterial Genus Geobacillus
  27. The Human Mesenteric Lymph Node Microbiome Differentiates Between Crohn’s Disease and Ulcerative Colitis
  28. The rumen microbiome: a crucial consideration when optimising milk and meat production and nitrogen utilisation efficiency
  29. Tracing mother-infant transmission of bacteriophages by means of a novel analytical tool for shotgun metagenomic datasets: METAnnotatorX
  30. The potency of the broad spectrum bacteriocin, bactofencin A, against staphylococci is highly dependent on primary structure, N-terminal charge and disulphide formation
  31. Mesophilic Sporeformers Identified in Whey Powder by Using Shotgun Metagenomic Sequencing
  32. A Diverse Range of Human Gut Bacteria Have the Potential To Metabolize the Dietary Component Gallic Acid
  33. Heterologous Expression of Biopreservative Bacteriocins With a View to Low Cost Production
  34. Genomic Characterization of Sulphite Reducing Bacteria Isolated From the Dairy Production Chain
  35. Effect of milk centrifugation and incorporation of high heat-treated centrifugate on the microbial composition and levels of volatile organic compounds of Maasdam cheese
  36. Oral Delivery of Nisin in Resistant Starch Based Matrices Alters the Gut Microbiota in Mice
  37. Sequencing of the Cheese Microbiome and Its Relevance to Industry
  38. Early Salmonella Typhimurium infection in pigs disrupts Microbiome composition and functionality principally at the ileum mucosa
  39. A Prospective Metagenomic and Metabolomic Analysis of the Impact of Exercise and/or Whey Protein Supplementation on the Gut Microbiome of Sedentary Adults
  40. Fighting biofilms with lantibiotics and other groups of bacteriocins
  41. Loss of MicroRNA-21 Influences the Gut Microbiota, Causing Reduced Susceptibility in a Murine Model of Colitis
  42. Gut microbiota as a source of novel antimicrobials
  43. Species classifier choice is a key consideration when analysing low-complexity food microbiome data
  44. Fecal Microbiota Transplantation in Gestating Sows and Neonatal Offspring Alters Lifetime Intestinal Microbiota and Growth in Offspring
  45. The intestinal protist Blastocystis is not a common member of the healthy infant gut microbiota in a Westernized country (Ireland)
  46. Post-weaning social isolation of rats leads to long-term disruption of the gut microbiota-immune-brain axis
  47. Novel insights into the microbiology of fermented dairy foods
  48. Omics-Based Insights into Flavor Development and Microbial Succession within Surface-Ripened Cheese
  49. Build the Read: A Hands-On Activity for Introducing Microbiology Students to NGS and Bioinformatics.
  50. Genome Sequence of Geobacillus stearothermophilus DSM 458, an Antimicrobial-Producing Thermophilic Bacterium, Isolated from a Sugar Beet Factory
  51. Plantaricyclin A, a Novel Circular Bacteriocin Produced by Lactobacillus plantarum NI326: Purification, Characterization, and Heterologous Production
  52. Application of bacteriocin-producing Enterococcus faecium isolated from donkey milk, in the bio-control of Listeria monocytogenes in fresh whey cheese
  53. Lack of Heterogeneity in Bacteriocin Production Across a Selection of Commercial Probiotic Products
  54. Metagenome-based surveillance and diagnostic approaches to studying the microbial ecology of food production and processing environments
  55. Bacteriocin with broad spectrum of activity
  56. Crop Establishment Practices Are a Driver of the Plant Microbiota in Winter Oilseed Rape (Brassica napus)
  57. High-throughput metataxonomic characterization of the raw milk microbiota identifies changes reflecting lactation stage and storage conditions
  58. Use of enhanced nisin derivatives in combination with food-grade oils or citric acid to control Cronobacter sakazakii and Escherichia coli O157:H7
  59. The Fungal Frontier: A Comparative Analysis of Methods Used in the Study of the Human Gut Mycobiome
  60. Whole-Genome Shotgun Sequence of Salmonella bongori, First Isolated in Northwestern Italy
  61. Whey protein effects on energy balance link the intestinal mechanisms of energy absorption with adiposity and hypothalamic neuropeptide gene expression
  62. Bacteriocin-Antimicrobial Synergy: A Medical and Food Perspective
  63. Strain-Level Metagenomic Analysis of the Fermented Dairy Beverage Nunu Highlights Potential Food Safety Risks
  64. Controlled functional expression of the bacteriocins pediocin PA-1 and bactofencin A in Escherichia coli
  65. Exploring a Possible Link between the Intestinal Microbiota and Feed Efficiency in Pigs
  66. The influence of rosuvastatin on the gastrointestinal microbiota and host gene expression profiles
  67. A Profile Hidden Markov Model to investigate the distribution and frequency of LanB-encoding lantibiotic modification genes in the human oral and gut microbiome
  68. Erratum to: The altered gut microbiota in adults with cystic fibrosis
  69. Insights into the Mode of Action of the Sactibiotic Thuricin CD
  70. Forgotten fungi—the gut mycobiome in human health and disease
  71. Health benefits of fermented foods: microbiota and beyond
  72. Drunk bugs: Chronic vapour alcohol exposure induces marked changes in the gut microbiome in mice
  73. The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level
  74. The altered gut microbiota in adults with cystic fibrosis
  75. Translating Omics to Food Microbiology
  76. Unravelling the metabolic impact of SBS-associated microbial dysbiosis: Insights from the piglet short bowel syndrome model
  77. Correction for Walsh et al., Microbial Succession and Flavor Production in the Fermented Dairy Beverage Kefir
  78. Detection and Enumeration of Spore-Forming Bacteria in Powdered Dairy Products
  79. ‘Microbes in sport’ – The potential role of the gut microbiota in athlete health and performance
  80. Gut microbiota: implications for sports and exercise medicine
  81. Preface to the Fourth Edition
  82. Microbiome Changes During Ripening
  83. Microbiota of Raw Milk and Raw Milk Cheeses
  84. A Bioengineered Nisin Derivative, M21A, in Combination with Food Grade Additives Eradicates Biofilms of Listeria monocytogenes
  85. Short bowel syndrome (SBS)-associated alterations within the gut-liver axis evolve early and persist long-term in the piglet model of short bowel syndrome
  86. Impacts of Seasonal Housing and Teat Preparation on Raw Milk Microbiota: a High-Throughput Sequencing Study
  87. Prevalence and genetic diversity of Blastocystis in family units living in the United States
  88. Bacteriocin production: a relatively unharnessed probiotic trait?
  89. Synergistic Nisin-Polymyxin Combinations for the Control of Pseudomonas Biofilm Formation
  90. New Weapons to Fight Old Enemies: Novel Strategies for the (Bio)control of Bacterial Biofilms in the Food Industry
  91. Microbial Succession and Flavor Production in the Fermented Dairy Beverage Kefir
  92. The bacteriocin bactofencin A subtly modulates gut microbial populations
  93. Miscanthus biochar promotes growth of spring barley and shifts bacterial community structures including phosphorus and sulfur mobilizing bacteria
  94. 16S rRNA gene sequencing of mock microbial populations- impact of DNA extraction method, primer choice and sequencing platform
  95. The efficacy of thuricin CD, tigecycline, vancomycin, teicoplanin, rifampicin and nitazoxanide, independently and in paired combinations against Clostridium difficile biofilms and planktonic cells
  96. Influence of GABA and GABA-producing Lactobacillus brevis DPC 6108 on the development of diabetes in a streptozotocin rat model
  97. The Microbiota and Health Promoting Characteristics of the Fermented Beverage Kefir
  98. In Vitro Activities of Nisin and Nisin Derivatives Alone and In Combination with Antibiotics against Staphylococcus Biofilms
  99. Bacteriocins: Novel Solutions to Age Old Spore-Related Problems?
  100. Compromised Lactobacillus helveticus starter activity in the presence of facultative heterofermentative Lactobacillus casei DPC6987 results in atypical eye formation in Swiss-type cheese
  101. Comparative Genomic Analysis Reveals a Diverse Repertoire of Genes Involved in Prokaryote-Eukaryote Interactions within the Pseudovibrio Genus
  102. Draft Genome Sequence of Lactobacillus casei DPC6800, an Isolate with the Potential to Diversify Flavor in Cheese
  103. Comparing Apples and Oranges?: Next Generation Sequencing and Its Impact on Microbiome Analysis
  104. FoodMicrobionet: A database for the visualisation and exploration of food bacterial communities based on network analysis
  105. Somatic/gonadal mosaicism for structural autosomal rearrangements: female predominance among carriers of gonadal mosaicism for unbalanced rearrangements
  106. A novel method of microsatellite genotyping-by-sequencing using individual combinatorial barcoding
  107. Detection of presumptive Bacillus cereus in the Irish dairy farm environment
  108. Value of Microbial Genome Sequencing for Probiotic Strain Identification and Characterization
  109. The Prevalence and Control of Bacillus and Related Spore-Forming Bacteria in the Dairy Industry
  110. Compared to casein, bovine lactoferrin reduces plasma leptin and corticosterone and affects hypothalamic gene expression without altering weight gain or fat mass in high fat diet fed C57/BL6J mice
  111. Bioengineering Lantibiotics for Therapeutic Success
  112. High-throughput DNA sequencing to survey bacterial histidine and tyrosine decarboxylases in raw milk cheeses
  113. Re: Gut microbiota depletion from early adolescence in mice: Implications for brain and behaviour
  114. Correction: N-3 Polyunsaturated Fatty Acids (PUFAs) Reverse the Impact of Early-Life Stress on the Gut Microbiota
  115. Prenatal stress-induced alterations in major physiological systems correlate with gut microbiota composition in adulthood
  116. Generation of the antimicrobial peptide caseicin A from casein by hydrolysis with thermolysin enzymes
  117. N-3 Polyunsaturated Fatty Acids (PUFAs) Reverse the Impact of Early-Life Stress on the Gut Microbiota
  118. In silico identification of bacteriocin gene clusters in the gastrointestinal tract, based on the Human Microbiome Project’s reference genome database
  119. Impact of Environmental Factors on Bacteriocin Promoter Activity in Gut-Derived Lactobacillus salivarius
  120. Gut microbiota depletion from early adolescence in mice: Implications for brain and behaviour
  121. Bovine serum albumin as the dominant form of dietary protein reduces subcutaneous fat mass, plasma leptin and plasma corticosterone in high fat-fed C57/BL6J mice
  122. The Sactibiotic Subclass of Bacteriocins: An Update
  123. Biotechnological applications of functional metagenomics in the food and pharmaceutical industries
  124. Bioengineering of the model lantibiotic nisin
  125. Nisin H Is a New Nisin Variant Produced by the Gut-Derived Strain Streptococcus hyointestinalis DPC6484
  126. Development and Application of a Blastocystis Subtype-Specific PCR Assay Reveals that Mixed-Subtype Infections Are Common in a Healthy Human Population
  127. Evaluation of Lactococcus lactis Isolates from Nondairy Sources with Potential Dairy Applications Reveals Extensive Phenotype-Genotype Disparity and Implications for a Revised Species
  128. Antimicrobial antagonists against food pathogens: a bacteriocin perspective
  129. The metabolic role of the microbiota
  130. A Bioengineered Nisin Derivative to Control Biofilms of Staphylococcus pseudintermedius
  131. Lantibiotic Resistance
  132. Exercise and the microbiota
  133. Proteomics as the final step in the functional metagenomics study of antimicrobial resistance
  134. Anaerobic sporeformers and their significance with respect to milk and dairy products
  135. Dietary trans-10, cis-12-conjugated linoleic acid alters fatty acid metabolism and microbiota composition in mice
  136. Engineered nisin variants control Listeria in food
  137. Temporal and Spatial Differences in Microbial Composition during the Manufacture of a Continental-Type Cheese
  138. Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers
  139. Changes in the colon microbiota and intestinal cytokine gene expression following minimal intestinal surgery
  140. Streptozotocin-induced type-1-diabetes disease onset in Sprague–Dawley rats is associated with an altered intestinal microbiota composition and decreased diversity
  141. Bacteriocin Mining in Metagenomes
  142. Marine Pseudovibrio sp. as a Novel Source of Antimicrobials
  143. The potential for emerging therapeutic options forClostridium difficileinfection
  144. Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease
  145. Exopolysaccharide-Producing Probiotic Lactobacilli Reduce Serum Cholesterol and Modify Enteric Microbiota in ApoE-Deficient Mice1,2
  146. Identification of Aminoglycoside and β-Lactam Resistance Genes from within an Infant Gut Functional Metagenomic Library
  147. The microbial eukaryoteBlastocystisis a prevalent and diverse member of the healthy human gut microbiota
  148. Author response: linking lifestyle and microbes
  149. Fermented beverages with health-promoting potential: Past and future perspectives
  150. Exercise and associated dietary extremes impact on gut microbial diversity
  151. An ‘Upp'-turn in bacteriocin receptor identification
  152. Draft Genome Sequence of Campylobacter ureolyticus Strain CIT007, the First Whole-Genome Sequence of a Clinical Isolate
  153. Heterologous Expression of Thuricin CD Immunity Genes in Listeria monocytogenes
  154. Sequence-based analysis of the bacterial and fungal compositions of multiple kombucha (tea fungus) samples
  155. Beneficial modulation of the gut microbiota
  156. Impact of dietary fatty acids on metabolic activity and host intestinal microbiota composition in C57BL/6J mice
  157. Protein Quality and the Protein to Carbohydrate Ratio within a High Fat Diet Influences Energy Balance and the Gut Microbiota In C57BL/6J Mice
  158. A degenerate PCR-based strategy as a means of identifying homologues of aminoglycoside and β-lactam resistance genes in the gut microbiota
  159. Atypical Listeria innocua strains possess an intact LIPI-3
  160. Generation of Nonpolar Deletion Mutants in Listeria monocytogenes Using the “SOEing” Method
  161. In Silico Assigned Resistance Genes Confer Bifidobacterium with Partial Resistance to Aminoglycosides but Not to Β-Lactams
  162. Intensive Mutagenesis of the Nisin Hinge Leads to the Rational Design of Enhanced Derivatives
  163. Interactions between gut microbiota, food and the obese host
  164. Bactofencin A, a New Type of Cationic Bacteriocin with Unusual Immunity
  165. Sequence-Based Analysis of the Intestinal Microbiota of Sows and Their Offspring Fed Genetically Modified Maize Expressing a Truncated Form of Bacillus thuringiensis Cry1Ab Protein (Bt Maize)
  166. Tn6188 - A Novel Transposon in Listeria monocytogenes Responsible for Tolerance to Benzalkonium Chloride
  167. Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat
  168. Sequence-based analysis of the microbial composition of water kefir from multiple sources
  169. The complex microbiota of raw milk
  170. The microbial content of raw and pasteurized cow milk as determined by molecular approaches
  171. Sequencing-Based Analysis of the Bacterial and Fungal Composition of Kefir Grains and Milks from Multiple Sources
  172. Bacteriocin production by Bifidobacterium spp. A review
  173. Bacterial Communities Established in Bauxite Residues with Different Restoration Histories
  174. Targeting the Microbiota to Address Diet-Induced Obesity: A Time Dependent Challenge
  175. Subtilomycin: A New Lantibiotic from Bacillus subtilis Strain MMA7 Isolated from the Marine Sponge Haliclona simulans
  176. Gut microbial diversity is reduced and is associated with colonic inflammation in a piglet model of short bowel syndrome
  177. Analysis of Anti-Clostridium difficile Activity of Thuricin CD, Vancomycin, Metronidazole, Ramoplanin, and Actagardine, both Singly and in Paired Combinations
  178. Strategies to improve the bacteriocin protection provided by lactic acid bacteria
  179. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ
  180. Saturation Mutagenesis of Lysine 12 Leads to the Identification of Derivatives of Nisin A with Enhanced Antimicrobial Activity
  181. Saturation mutagenesis of selected residues of the α-peptide of the lantibiotic lacticin 3147 yields a derivative with enhanced antimicrobial activity
  182. Microbiota diversity and stability of the preterm neonatal ileum and colon of two infants
  183. Microbial Composition of Human Appendices from Patients following Appendectomy
  184. The individual-specific and diverse nature of the preterm infant microbiota
  185. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature
  186. Additions and corrections
  187. Antimicrobials
  188. In vivo activity of Nisin A and Nisin V against Listeria monocytogenes in mice
  189. Microbial production of bacteriocins for use in foods
  190. Nucleic acid-based approaches to investigate microbial-related cheese quality defects
  191. The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria
  192. Bacteriocin Mining in Metagenomes
  193. Bacteriocins — a viable alternative to antibiotics?
  194. Bioengineering
  195. Assessment of the Bacteriocinogenic Potential of Marine Bacteria Reveals Lichenicidin Production by Seaweed-Derived Bacillus spp.
  196. Bioengineered Nisin A Derivatives with Enhanced Activity against Both Gram Positive and Gram Negative Pathogens
  197. Lantibiotic Production by Pathogenic Microorganisms
  198. High-Throughput Sequencing Reveals the Incomplete, Short-Term Recovery of Infant Gut Microbiota following Parenteral Antibiotic Treatment with Ampicillin and Gentamicin
  199. Insights into Lantibiotic Immunity Provided by Bioengineering of LtnI
  200. High-Throughput Sequencing for Detection of Subpopulations of Bacteria Not Previously Associated with Artisanal Cheeses
  201. Supernumerary marker chromosomes derived from chromosome 6: Cytogenetic, molecular cytogenetic, and array CGH characterization
  202. The Effect of Feeding Bt MON810 Maize to Pigs for 110 Days on Intestinal Microbiota
  203. Lacticin 3147 - Biosynthesis, Molecular Analysis, Immunity, Bioengineering and Applications
  204. Composition of the early intestinal microbiota
  205. The gut microbiota and its relationship to diet and obesity
  206. Impact of leucine on energy balance
  207. A comparison of methods used to extract bacterial DNA from raw milk and raw milk cheese
  208. Contrasting effects of Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the composition of murine brain fatty acids and gut microbiota
  209. High-Throughput Sequence-Based Analysis of the Intestinal Microbiota of Weanling Pigs Fed Genetically Modified MON810 Maize Expressing Bacillus thuringiensis Cry1Ab (Bt Maize) for 31 Days
  210. Comparison of the Potency of the Lipid II Targeting Antimicrobials Nisin, Lacticin 3147 and Vancomycin Against Gram-Positive Bacteria
  211. Cronobacter spp. in Powdered Infant Formula
  212. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity
  213. Assessing the Contributions of the LiaS Histidine Kinase to the Innate Resistance of Listeria monocytogenes to Nisin, Cephalosporins, and Disinfectants
  214. Technological characterization of bacteriocin producing Lactococcus lactis strains employed to control Listeria monocytogenes in Cottage cheese
  215. Bioengineered nisin derivatives with enhanced activity in complex matrices
  216. Extensive Manipulation of Caseicins A and B Highlights the Tolerance of These Antimicrobial Peptides to Change
  217. Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters
  218. Antimicrobial Peptides as Therapeutic Agents
  219. Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: Bacteriocins and conjugated linoleic acid
  220. The Lantibiotic Lacticin 3147 Prevents Systemic Spread ofStaphylococcus aureusin a Murine Infection Model
  221. Homologues and Bioengineered Derivatives of LtnJ Vary in Ability to Form D-Alanine in the Lantibiotic Lacticin 3147
  222. ThespiFEGLocus in Streptococcus infantarius subsp. infantarius BAA-102 Confers Protection against Nisin U
  223. Molecular approaches to analysing the microbial composition of raw milk and raw milk cheese
  224. Bacteriocin Production: a Probiotic Trait?
  225. Impact of the broad-spectrum antimicrobial peptide, lacticin 3147, on Streptococcus mutans growing in a biofilm and in human saliva
  226. Production of Multiple Bacteriocins from a Single Locus by Gastrointestinal Strains of Lactobacillus salivarius
  227. Flagging flora: help from bacteriocins?
  228. Streptolysin S-like virulence factors: the continuing sagA
  229. Genome Mining for Radical SAM Protein Determinants Reveals Multiple Sactibiotic-Like Gene Clusters
  230. High-throughput sequence-based analysis of the bacterial composition of kefir and an associated kefir grain
  231. An International Network for Improving Health Properties of Food by Sharing our Knowledge on the Digestive Process
  232. Bacteriocins as Natural Antilisterial Food Preservatives
  233. The impact of nisin on sensitive and resistant mutants of Listeria monocytogenes in cottage cheese
  234. Fate and efficacy of lacticin 3147-producing Lactococcus lactis in the mammalian gastrointestinal tract
  235. Small intestine and microbiota
  236. Further Identification of Novel Lantibiotic Operons Using LanM-Based Genome Mining
  237. Altering the Composition of Caseicins A and B as a Means of Determining the Contribution of Specific Residues to Antimicrobial Activity
  238. Real-Time PCR Assay To Differentiate Listeriolysin S-Positive and -Negative Strains ofListeria monocytogenes
  239. The gene encoded antimicrobial peptides, a template for the design of novel anti-mycobacterial drugs
  240. The dawning of a ‘Golden era’ in lantibiotic bioengineering
  241. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models
  242. Effect of Bioengineering Lacticin 3147 Lanthionine Bridges on Specific Activity and Resistance to Heat and Proteases
  243. Bioengineering of a Nisin A-producing Lactococcus lactis to create isogenic strains producing the natural variants Nisin F, Q and Z
  244. Investigating the importance of charged residues in lantibiotics
  245. TelA Contributes to the Innate Resistance of Listeria monocytogenes to Nisin and Other Cell Wall-Acting Antibiotics
  246. Glutamate Decarboxylase-Mediated Nisin Resistance in Listeria monocytogenes
  247. Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria
  248. The ABC Transporter AnrAB Contributes to the Innate Resistance of Listeria monocytogenes to Nisin, Bacitracin, and Various β-Lactam Antibiotics
  249. Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon
  250. Synthesis of Trypsin-Resistant Variants of the Listeria-Active Bacteriocin Salivaricin P
  251. Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V
  252. In silico analysis highlights the frequency and diversity of type 1 lantibiotic gene clusters in genome sequenced bacteria
  253. Production of the Bsa Lantibiotic by Community-Acquired Staphylococcus aureus Strains
  254. Manipulation of charged residues within the two-peptide lantibiotic lacticin 3147
  255. Identification of a Novel Two-Peptide Lantibiotic, Lichenicidin, following Rational Genome Mining for LanM Proteins
  256. A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species
  257. Discovery of Medically Significant Lantibiotics
  258. Cross-immunity and immune mimicry as mechanisms of resistance to the lantibiotic lacticin 3147
  259. Isolation and Analysis of Bacteria with Antimicrobial Activities from the Marine Sponge Haliclona simulans Collected from Irish Waters
  260. Listeriolysin S, a Novel Peptide Haemolysin Associated with a Subset of Lineage I Listeria monocytogenes
  261. The generation of nisin variants with enhanced activity against specific Gram-positive pathogens
  262. Controlling Listeria monocytogenes in Cottage cheese through heterologous production of enterocin A by Lactococcus lactis
  263. Lantibiotic Immunity
  264. Two-Peptide Lantibiotics: A Medical Perspective
  265. A System for the Random Mutagenesis of the Two-Peptide Lantibiotic Lacticin 3147: Analysis of Mutants Producing Reduced Antibacterial Activities
  266. The glutamate decarboxylase acid resistance mechanism affects survival of Listeria monocytogenes LO28 in modified atmosphere-packaged foods
  267. Insertional Mutagenesis To Generate Lantibiotic Resistance in Lactococcus lactis
  268. Identification of a novel two-peptide lantibiotic, Haloduracin, produced by the alkaliphileBacillus haloduransC-125
  269. Relatedness between the two-component lantibiotics lacticin 3147 and staphylococcin C55 based on structure, genetics and biological activity
  270. Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design
  271. Bacteriocins: Biological tools for bio-preservation and shelf-life extension
  272. Contribution of Penicillin-Binding Protein Homologs to Antibiotic Resistance, Cell Morphology, and Virulence of Listeria monocytogenes EGDe
  273. Spontaneous resistance inLactococcus lactisIL1403 to the lantibiotic lacticin 3147
  274. Overproduction of Wild-Type and Bioengineered Derivatives of the Lantibiotic Lacticin 3147
  275. Posttranslational conversion of l -serines to d -alanines is vital for optimal production and activity of the lantibiotic lacticin 3147
  276. Food Microbiology: Bacteriocins: developing innate immunity for food
  277. Sequential Actions of the Two Component Peptides of the Lantibiotic Lacticin 3147 Explain Its Antimicrobial Activity at Nanomolar Concentrations
  278. Presence of GadD1 Glutamate Decarboxylase in Selected Listeria monocytogenes Strains Is Associated with an Ability To Grow at Low pH
  279. Microbial solutions to microbial problems; lactococcal bacteriocins for the control of undesirable biota in food
  280. Bacterial Lantibiotics: Strategies to Improve Therapeutic Potential
  281. Structural Characterization of Lacticin 3147, a Two-Peptide Lantibiotic with Synergistic Activity†
  282. Surviving the Acid Test: Responses of Gram-Positive Bacteria to Low pH
  283. A Food-Grade Approach for Functional Analysis and Modification of Native Plasmids in Lactococcus lactis
  284. The LisRK Signal Transduction System Determines the Sensitivity of Listeria monocytogenes to Nisin and Cephalosporins
  285. Bacterial stress response in Listeria monocytogenes: jumping the hurdles imposed by minimal processing
  286. A glutamate decarboxylase system protects Listeria monocytogenes in gastric fluid
  287. Analysis of the role of the Listeria monocytogenes F0F1-ATPase operon in the acid tolerance response
  288. Applications of Lactic Acid Bacteria-Produced Bacteriocins